| dc.contributor.author | Mateo, J | |
| dc.contributor.author | Carreira, S | |
| dc.contributor.author | de Bono, JS | |
| dc.date.accessioned | 2019-05-01T13:22:09Z | |
| dc.date.issued | 2019-10-01 | |
| dc.identifier.citation | European urology, 2019, 76 (4), pp. 459 - 460 | |
| dc.identifier.issn | 0302-2838 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/3213 | |
| dc.identifier.eissn | 1873-7560 | |
| dc.identifier.doi | 10.1016/j.eururo.2019.03.029 | |
| dc.format | Print-Electronic | |
| dc.format.extent | 459 - 460 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER | |
| dc.rights.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
| dc.subject | Humans | |
| dc.subject | Piperazines | |
| dc.subject | Phthalazines | |
| dc.subject | BRCA1 Protein | |
| dc.subject | BRCA2 Protein | |
| dc.subject | Mutation | |
| dc.subject | Male | |
| dc.subject | Ataxia Telangiectasia Mutated Proteins | |
| dc.subject | Prostatic Neoplasms, Castration-Resistant | |
| dc.subject | Biomarkers | |
| dc.subject | Poly(ADP-ribose) Polymerase Inhibitors | |
| dc.title | PARP Inhibitors for Advanced Prostate Cancer: Validating Predictive Biomarkers. | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2019-03-21 | |
| rioxxterms.versionofrecord | 10.1016/j.eururo.2019.03.029 | |
| rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
| rioxxterms.licenseref.startdate | 2019-10 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | European urology | |
| pubs.issue | 4 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Cancer Biomarkers | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Cancer Biomarkers | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Cancer Biomarkers | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Cancer Biomarkers | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
| pubs.publication-status | Published | |
| pubs.volume | 76 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Cancer Biomarkers | |
| icr.researchteam | Prostate Cancer Targeted Therapy Group | |
| dc.contributor.icrauthor | Carreira, Suzanne | |
| dc.contributor.icrauthor | De Bono, Johann | |
